In vitro antimycobacterial activity of 5-chloropyrazinamide
about
Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I.Mechanisms of Pyrazinamide Action and ResistanceMutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy.Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase IInhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomographyLoss of a Functionally and Structurally Distinct ld-Transpeptidase, LdtMt5, Compromises Cell Wall Integrity in Mycobacterium tuberculosis.Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactamsCharacterization of Mycobacterium smegmatis expressing the Mycobacterium tuberculosis fatty acid synthase I (fas1) gene.Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA.Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli
P2860
Q24538909-1CF132DB-C553-4189-8544-7A1A1789A0E4Q29304444-AE415735-5E2A-4656-BC68-3B6F2073E875Q33704769-5726B5FE-0D3F-4D70-90E6-E4252521A719Q35168078-C094B0EB-AC67-446D-A4B8-DBC0BBACD2C7Q35879089-0F02419F-5E8F-41FE-B0B4-74FDE2E426C8Q36075809-F93C4789-99A7-4ACA-A622-AE2391F8E4C9Q36267526-C4C571D7-A8DC-487B-AD5E-4F55814E6E33Q36283392-B0B19AA8-DC1A-42E9-898D-A578A0AFBE27Q36613180-3EA16651-A073-4B5A-AD60-FEC77B0B24CCQ37713160-E58B8DA0-2D3D-4EB9-87F5-821D3FF14794Q40909374-E0904CD6-FA00-4BEC-987F-0D4693AFB357Q41094161-12CFAD80-D91D-4152-B828-420F32054BF3Q42234921-C882E7A3-3314-4B86-ACC1-C710A64BE3A3
P2860
In vitro antimycobacterial activity of 5-chloropyrazinamide
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
In vitro antimycobacterial activity of 5-chloropyrazinamide
@ast
In vitro antimycobacterial activity of 5-chloropyrazinamide
@en
In vitro antimycobacterial activity of 5-chloropyrazinamide
@nl
type
label
In vitro antimycobacterial activity of 5-chloropyrazinamide
@ast
In vitro antimycobacterial activity of 5-chloropyrazinamide
@en
In vitro antimycobacterial activity of 5-chloropyrazinamide
@nl
prefLabel
In vitro antimycobacterial activity of 5-chloropyrazinamide
@ast
In vitro antimycobacterial activity of 5-chloropyrazinamide
@en
In vitro antimycobacterial activity of 5-chloropyrazinamide
@nl
P2093
P2860
P1476
In vitro antimycobacterial activity of 5-chloropyrazinamide
@en
P2093
M H Cynamon
R J Speirs
P2860
P407
P577
1998-02-01T00:00:00Z